Home
Home » companies

Halozyme

Halozyme rises on pancreatic cancer drug study

Halozyme rises on pancreatic cancer drug study
Yahoo/AP

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week
Motley Fool

ViroPharma: Generic Concerns Overblown, Pipeline Will Bring Revenue Diversity

ViroPharma: Generic Concerns Overblown, Pipeline Will Bring Revenue Diversity
Seeking Alpha

Halozyme Rallies On Success In Europe, US Next Target

Halozyme Rallies On Success In Europe, US Next Target
Seeking Alpha

Biogen, Baxter, Sanofi, Gilead Win EU Endorsements

Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com

3 Horrendous Health-Care Stocks This Week

3 Horrendous Health-Care Stocks This Week
Motley Fool

Halozyme Moving Higher On Fundamentals, Analyst Upgrade

Halozyme Moving Higher On Fundamentals, Analyst Upgrade
Seeking Alpha

Halozyme Therapeutics's Key Deal With Pfizer Is Significant

Halozyme Therapeutics's Key Deal With Pfizer Is Significant
Seeking Alpha

Pfizer’s Backing Spurs Halozyme's Growth

Pfizer’s Backing Spurs Halozyme's Growth
Motley Fool

Pfizer’s Backing Spurs Halozyme's Growth

Pfizer’s Backing Spurs Halozyme's Growth
Motley Fool